📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. (2013)

First Author: Egerton A

Attributed to: CANNABIDIOL AS A NOVEL THERAPEUTIC AGENT FOR PATIENTS AT ULTRA HIGH-RISK OF PSYCHOSIS: AN EXPERIMENTAL MEDICINE APPROACH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopsych.2012.11.017

PubMed Identifier: 23312565

Publication URI: http://europepmc.org/abstract/MED/23312565

Type: Journal Article/Review

Volume: 74

Parent Publication: Biological psychiatry

Issue: 2

ISSN: 0006-3223